Audiocure Pharma Gmbh

Audiocure Pharma Gmbh company information, Employees & Contact Information

To date, there are no approved drugs for the treatment of any sensorineural hearing loss disorder or tinnitus. At AudioCure Pharma we are determined to change this! Our vision is to turn incurable hearing loss into a treatable event. We are dedicated to the development of drug treatments for hearing disorders with a high unmet medical need. We have identified a new method of protecting and restoring the cellular key players that are critical to the hearing process. Therefore, our therapeutic approach goes beyond treating symptoms as we tackle the root cause of the disorders. Having successfully demonstrated preclinical proof of concept, our front-runner compound is currently in late stage preclinical development for the treatment of hearing loss. AudioCure is located in the vibrant capital of Germany, Berlin. Our offices are part of a cluster of high-tech companies and universities at the heart of the city. We are a team of highly skilled scientists and executives with a tight-knit network of academic partners, internationally renowned advisors and strategic investors. We also have close ties to the Charité University.

Company Details

Employees
16
Address
Schlegelstr, 9, Berlin,berlin 10115,germany
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Berlin, Berlin
Looking for a particular Audiocure Pharma Gmbh employee's phone or email?

Audiocure Pharma Gmbh Questions

News

InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy - Business Wire

InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy Business Wire

InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy - Yahoo Finance

InfectoPharm Invests in AudioCure to Advance Innovative Hearing Loss Therapy Yahoo Finance

AudioCure Pharma Awarded for Therapeutic Small Molecule for Hearing Loss - The Hearing Review

AudioCure Pharma Awarded for Therapeutic Small Molecule for Hearing Loss The Hearing Review

AudioCure Pharma: Novel compound AC102 restores noise-induced hearing loss in preclinical models - News-Medical

AudioCure Pharma: Novel compound AC102 restores noise-induced hearing loss in preclinical models News-Medical

InfectoPharm partners with AudioCure to advance hearing loss therapy - Tech.eu

InfectoPharm partners with AudioCure to advance hearing loss therapy Tech.eu

Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model - Business Wire

Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model Business Wire

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study - Yahoo Finance

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study Yahoo Finance

Top Audiocure Pharma Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant